PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIOPX vs. FTEC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


BIOPXFTEC
YTD Return7.99%2.40%
1Y Return40.90%32.98%
3Y Return (Ann)-1.35%9.80%
5Y Return (Ann)17.05%19.56%
10Y Return (Ann)15.95%19.79%
Sharpe Ratio1.981.77
Daily Std Dev20.24%18.33%
Max Drawdown-67.79%-34.95%
Current Drawdown-21.51%-6.64%

Correlation

-0.50.00.51.00.9

The correlation between BIOPX and FTEC is 0.88, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

BIOPX vs. FTEC - Performance Comparison

In the year-to-date period, BIOPX achieves a 7.99% return, which is significantly higher than FTEC's 2.40% return. Over the past 10 years, BIOPX has underperformed FTEC with an annualized return of 15.95%, while FTEC has yielded a comparatively higher 19.79% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
26.41%
20.11%
BIOPX
FTEC

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Baron Opportunity Fund

Fidelity MSCI Information Technology Index ETF

BIOPX vs. FTEC - Expense Ratio Comparison

BIOPX has a 1.31% expense ratio, which is higher than FTEC's 0.08% expense ratio.


BIOPX
Baron Opportunity Fund
Expense ratio chart for BIOPX: current value at 1.31% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.31%
Expense ratio chart for FTEC: current value at 0.08% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.08%

Risk-Adjusted Performance

BIOPX vs. FTEC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Baron Opportunity Fund (BIOPX) and Fidelity MSCI Information Technology Index ETF (FTEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIOPX
Sharpe ratio
The chart of Sharpe ratio for BIOPX, currently valued at 1.98, compared to the broader market-1.000.001.002.003.004.001.98
Sortino ratio
The chart of Sortino ratio for BIOPX, currently valued at 2.62, compared to the broader market-2.000.002.004.006.008.0010.0012.002.62
Omega ratio
The chart of Omega ratio for BIOPX, currently valued at 1.33, compared to the broader market0.501.001.502.002.503.001.33
Calmar ratio
The chart of Calmar ratio for BIOPX, currently valued at 0.88, compared to the broader market0.002.004.006.008.0010.0012.000.88
Martin ratio
The chart of Martin ratio for BIOPX, currently valued at 7.13, compared to the broader market0.0010.0020.0030.0040.0050.0060.007.13
FTEC
Sharpe ratio
The chart of Sharpe ratio for FTEC, currently valued at 1.77, compared to the broader market-1.000.001.002.003.004.001.77
Sortino ratio
The chart of Sortino ratio for FTEC, currently valued at 2.46, compared to the broader market-2.000.002.004.006.008.0010.0012.002.46
Omega ratio
The chart of Omega ratio for FTEC, currently valued at 1.30, compared to the broader market0.501.001.502.002.503.001.30
Calmar ratio
The chart of Calmar ratio for FTEC, currently valued at 1.62, compared to the broader market0.002.004.006.008.0010.0012.001.62
Martin ratio
The chart of Martin ratio for FTEC, currently valued at 7.51, compared to the broader market0.0010.0020.0030.0040.0050.0060.007.51

BIOPX vs. FTEC - Sharpe Ratio Comparison

The current BIOPX Sharpe Ratio is 1.98, which roughly equals the FTEC Sharpe Ratio of 1.77. The chart below compares the 12-month rolling Sharpe Ratio of BIOPX and FTEC.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
1.98
1.77
BIOPX
FTEC

Dividends

BIOPX vs. FTEC - Dividend Comparison

BIOPX has not paid dividends to shareholders, while FTEC's dividend yield for the trailing twelve months is around 0.76%.


TTM20232022202120202019201820172016201520142013
BIOPX
Baron Opportunity Fund
0.00%0.00%0.00%8.71%6.96%7.33%5.28%15.58%13.52%10.92%5.66%6.13%
FTEC
Fidelity MSCI Information Technology Index ETF
0.76%0.77%0.93%0.63%0.83%1.03%1.20%0.96%1.25%1.27%1.09%0.18%

Drawdowns

BIOPX vs. FTEC - Drawdown Comparison

The maximum BIOPX drawdown since its inception was -67.79%, which is greater than FTEC's maximum drawdown of -34.95%. Use the drawdown chart below to compare losses from any high point for BIOPX and FTEC. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-21.51%
-6.64%
BIOPX
FTEC

Volatility

BIOPX vs. FTEC - Volatility Comparison

Baron Opportunity Fund (BIOPX) has a higher volatility of 6.30% compared to Fidelity MSCI Information Technology Index ETF (FTEC) at 5.87%. This indicates that BIOPX's price experiences larger fluctuations and is considered to be riskier than FTEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%NovemberDecember2024FebruaryMarchApril
6.30%
5.87%
BIOPX
FTEC